COMMUNIQUÉS West-GlobeNewswire

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
06/03/2018
FIT Biotech Oy Company release March 6, 2018 at 03:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Calithera to Present at Cowen & Company 38th Annual Health Care Conference
06/03/2018
SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical-stage biotechnology company focused on the development of novel cancer therapeutics, today [...]
Achaogen to Present at the Cowen and Company 38th Annual Health Care Conference
06/03/2018
-- Company presentation scheduled for March 13, 2018 -- SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative [...]
Allscripts launches industry’s first machine learning EHR
06/03/2018
LAS VEGAS, March 06, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions (NASDAQ: MDRX ) unveiled its new electronic health record (EHR), Avenel™, at the annual HIMSS conference today. Mobile-first and cloud-based [...]
Radius Health to Present at the Cowen 38th Annual Health Care Conference
06/03/2018
WALTHAM, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) announced today that Jesper Høiland, President and CEO of the Company, will present a corporate update at Cowen’s 38th Annual Health [...]
Caladrius Biosciences Acquires an Exclusive License to a Late Stage CD34+ Cell Therapy Program for the Treatment of Refractory Angina
06/03/2018
BASKING RIDGE, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Foamix Pharmaceuticals to Present at the Cowen & Company 38th Annual Health Care Conference
06/03/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Provant Health Boosts Flu Immunity for Employees Across the U.S.
06/03/2018
OLATHE, Kan., March 06, 2018 (GLOBE NEWSWIRE) -- Provant Health announced today that its convenient influenza vaccination (“flu shot”) options for employers have resulted in nearly 100,000 workers across the U.S. being [...]
Avinger to Announce Fourth Quarter 2017 and Full Year 2017 Results on March 19th, 2018
06/03/2018
REDWOOD CITY, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will release its [...]
Altimmune to Participate at Two Investor Conferences in March
06/03/2018
GAITHERSBURG, Md., March 06, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, will provide a [...]
CymaBay to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15
06/03/2018
NEWARK, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
Allena Pharmaceuticals Initiates First Phase 3 Trial for ALLN-177 in Patients with Enteric Hyperoxaluria
06/03/2018
URIROX-1 TM is the Largest Controlled Trial of a Novel Therapeutic for this Underserved Patient Population - Topline Data Expected in Second Half of 2019 - ALLN-177 has Potential to be the First FDA-Approved Treatment [...]
PhaseBio to Present at March Investor Conferences
06/03/2018
MALVERN, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced that Chief Executive [...]
Albireo to Present at 38th Annual Cowen and Company Health Care Conference
06/03/2018
BOSTON, March 06, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]
CareDx to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on March 22, 2018
06/03/2018
BRISBANE, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
MyoKardia to Present at the Cowen and Company 38th Annual Health Care Conference
06/03/2018
SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
GBT Appoints Industry Leader David L. Johnson as Chief Commercial Officer
06/03/2018
SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT or the “Company”) (Nasdaq: GBT ) today announced the appointment of David L. Johnson as chief commercial officer, [...]
3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer
06/03/2018
TORONTO, March 06, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the " Company " or " 3DS "), a personalized medicine company with a proprietary software platform based on the three- [...]
Phase 1 Clinical Data Demonstrating CLR 124 Uptake in Brain Tumors Accepted for Oral Presentation at the 12th World Congress of the World Federation of Nuclear Medicine and Biology
06/03/2018
MADISON, Wis., March 06, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]

Pages